Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1445 participants
OBSERVATIONAL
2022-11-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Over the years, millions of people worldwide have attended immersive personal development seminars aiming to improve participants' health behaviors and wellness. Nevertheless, there's a scarcity of large-scale studies to assess their effects on behavior change and investigate their mechanism of action. A recent publication by the Science of Behavior Change Program (SOBC), launched by the National Institute of Health (NIH), recognized that: "science has not yet delivered a unified understanding of basic mechanisms of behavior change across a broad range of health-related behaviors, limiting progress in the development and translation of effective and efficacious behavioral intervention." As such, understanding the mechanisms underlying sustainable behavior change is key.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Methods From Computational Psychology be Used to Phenotype Individuals Most Likely to be Non-adherent to Fitness Goals?
NCT04783298
Digital Tools for Coping With Chronic Pain
NCT03234439
Contemplative Well-being Apps for the Workplace
NCT03452670
PERsonal ContExtual Precision healTh
NCT03349918
Health Experiences & Early Life Disadvantages
NCT02400593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DWD participants
Individuals that voluntarily chose to participate in DWD seminar.
Date With Destiny (DWD) Seminar
6 days of immersive seminar
Matched control group
Individuals that voluntarily chose to from the US population matched by gender, age, education, ethnicity and income
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Date With Destiny (DWD) Seminar
6 days of immersive seminar
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaker
* Live in the US
* Participate in the DWD seminar (December 2-7, 2022)
Exclusion Criteria
* Serious active comorbidity or terminal illness
* Pregnancy
* Participation in any other clinical study focusing on psychological or behavioral intervention.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Snyder
Chair, Dept. of Genetics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mike Snyder, PhD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Shahar Lev-Ari, PhD
Role: PRINCIPAL_INVESTIGATOR
Stanford University & Tel-Aviv University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford university
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
66491, 68645
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.